Synopsis:
Suneeta Reddy, the promoter of Apollo Hospitals, plans to sell a 1.25% stake in the company through block deals worth approximately Rs. 1,395 crore.
Asia’s largest healthcare service provider is in the spotlight today after its promoters intend to sell a large portion of their stake through block deals, which could result in a significant change in ownership and attract strong investor interest.
With a market capitalization of Rs. 1,13,892 crore, Apollo Hospitals Enterprise Limited is trading at Rs. 7,918.50, down by 0.1 percent from its previous close of Rs. 7,926.50 per equity share.
What’s the deal?
According to sources, Apollo Hospitals Enterprise promoter Suneeta Reddy is likely to sell a 1.25 percent stake in the company through block deals. The transaction, valued at around Rs. 1,395 crore, has a floor price set at Rs. 7,747 per share. As of June 2025, Suneeta Reddy’s shareholding in Apollo Hospitals Enterprise stands at 3.36 percent, representing 48,34,305 shares.
Also Read: Auto ancillary stock jumps 7% after receiving ₹70 Cr order to supply material handling components
About the company
Apollo Hospitals was founded in 1983 by Dr. Prathap C. Reddy, and it is India’s first corporate hospital as well as a pioneer in private healthcare. It has grown into Asia’s leading integrated healthcare provider, with a strong presence in hospitals, pharmacies, diagnostics, primary care, and retail health services.
The company’s revenue for Q1FY26 increased by 14.86 percent year over year from Rs. 5,086 crore to Rs. 5,842 crore. Whereas, net profit rose by 39.56 percent yearly from Rs. 316 crore to Rs. 441 crore.
It is trading at a price-to-earnings (P/E) ratio of 72.3x, which is higher than the industry average of 64x. A return on equity (ROE) of about 18.4 percent and a return on capital employed (ROCE) of about 16.6 percent demonstrate the company’s financial position. The debt-to-equity ratio of the company stands at 0.96.
Written by Akshay Sanghavi
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
